🇺🇸 TDV in United States
7 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 7
Most-reported reactions
- Cd4 Lymphocytes Abnormal — 1 report (14.29%)
- Cd4 Lymphocytes Increased — 1 report (14.29%)
- Drug Resistance — 1 report (14.29%)
- Genital Herpes — 1 report (14.29%)
- Herpes Simplex — 1 report (14.29%)
- Immune Reconstitution Syndrome — 1 report (14.29%)
- Viral Load Increased — 1 report (14.29%)
TDV in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Diabetes approved in United States
Frequently asked questions
Is TDV approved in United States?
TDV does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for TDV in United States?
Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.